News on haematological malignancies
Finding and targeting a tumour’s sweet spot to eradicate AML
A highly aggressive common form of leukaemia which is activated by mutations in signalling molecules…
Browsing: Haematology
Protected: Tecartus® (Brexucabtagene Autoleucel) CAR T-cell therapy now funded in Australia for the treatment of relapsed or refractory mantle cell lymphoma (r/r MCL)
This content is password-protected. To view it, please enter the password below. Password:
A “massive leap”: New test for blood cancer funded by MBS
Peter Mac scientists have been part of a nationwide push to get an important genetic…
Drug shows promise in first-in-human trial for relapsed blood cancer
A new targeted drug, studied by researchers at The Ohio State University Comprehensive Cancer Center –…
Discovery unlocks potential new arsenal to target leukaemia and other cancers
A discovery by a QIMR Berghofer-led team of international scientists has potentially unlocked an entirely…
Dietary selenium may help combat myeloid leukaemia, mouse study suggests
Selenium-enriched diets may help ward off myeloid leukaemia, and a new study led by researchers…
New cell model to help find treatments for B-cell acute lymphoblastic leukaemia
B-cell acute lymphoblastic leukaemia (B-ALL) is one of the most common forms of childhood cancer.…
Cancer vaccine shows promise for multiple myeloma in small trial
A dendritic cell vaccine administered before and after autologous stem cell transplant (ASCT) was safe…
New insights to enhance treatment and diagnosis of blood cancer
A ground-breaking study by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National…
Patients with AML who received vitamin C/D supplements had fewer complications, but no OS benefit seen
Patients with acute myeloid leukaemia (AML) who received vitamin C and D supplements while undergoing…